South Oklahoma Heart Research Group

5200 East Interstate 240 Service Road
Oklahoma City, Oklahoma 73135

We've found

3 trials

at this facility

EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Oklahoma City, OK

EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Oklahoma City, OK

Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Oklahoma City, OK

Use our guide to learn which trials are right for you!